When it comes to weight loss, GLP-1 receptor agonists, like semaglutide, should be:

  • a last ditch option for those with multiple co-morbidities. (3%, 3 Votes)
  • a 2nd line option; used only after lifestyle changes have been implemented. (36%, 35 Votes)
  • considered as an adjunct to lifestyle to anyone with a BMI > 30 (54%, 52 Votes)
  • offered to anyone who needs to kick-start weight loss (7%, 7 Votes)

Total Voters: 97

Start Date: June 2, 2021 @ 3:44 PM
End Date: July 11, 2021 @ 11:00 AM

Mindfulness-Base Stress Reduction (MBSR) programs (8+week meditation and yoga training) ...

  • might make you "feel good" but don't have evidence-based benefits. (5%, 2 Votes)
  • are likely effective as an adjunctive treatment for stress and anxiety. (48%, 19 Votes)
  • have a wide range of proven benefits and should be covered by payers. (35%, 14 Votes)
  • should be routinely offered and as common as ordering a screening lipid panel. (12%, 5 Votes)

Total Voters: 40

Start Date: March 24, 2021 @ 9:00 AM
End Date: June 2, 2021 @ 3:53 PM

In an obese woman with type 2 DM who becomes pregnant, metformin ...

  • should be discontinued immediately and insulin therapy initiated. (33%, 22 Votes)
  • should be discontinued if good glycemic control can't be achieved. (14%, 9 Votes)
  • should be continued to reduce pregnancy-related weight gain. (6%, 4 Votes)
  • should be continued to improve maternal and fetal outcomes. (47%, 31 Votes)

Total Voters: 66

Start Date: February 15, 2021 @ 2:10 PM
End Date: March 25, 2021 @ 1:06 AM

 Page 10 of 12  « First ... «  3  4  5  6  7  8  9  10  11  12  »